High throughput flow cytometry identifies small molecule inhibitors for drug repurposing in T-ALL

Kinase inhibitors have dramatically increased patient survival in a multitude of cancers, including hematological malignancies. However, kinase inhibitors have not yet been integrated into current clinical trials for patients with T-cell lineage acute lymphoblastic leukemia (T-ALL). In this study, w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:SLAS Discov
Main Authors: Perez, Dominique R., Nickl, Christian K., Waller, Anna, Delgado-Martin, Cristina, Woods, Travis, Sharma, Nitesh D., Hermiston, Michelle L, Loh, Mignon L., Hunger, Stephen P., Winter, Stuart S., Chigaev, Alexandre, Edwards, Bruce, Sklar, Larry A., Matlawska-Wasowska, Ksenia
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292518/
https://ncbi.nlm.nih.gov/pubmed/29746793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2472555218774248
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados